Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients

Gianmaria Baldin(Agostino Gemelli University Polyclinic), Simona Di Giambenedetto(Università Cattolica del Sacro Cuore), Gaetana Sterrantino(University of Florence), Arturo Ciccullo(San Salvatore Hospital), Manuela Colafigli(San Gallicano Hospital), Alberto Borghetti(Università Cattolica del Sacro Cuore), Gabriella d’Ettorre(Policlinico Umberto I), Vanni Borghi(University of Modena and Reggio Emilia), William Gennari(University of Modena and Reggio Emilia), Maria Vittoria Cossu(Luigi Sacco Hospital), Cristina Mussini(University of Modena and Reggio Emilia), Stefano Rusconi(University of Milan), Amedeo Capetti(Luigi Sacco Hospital)
International Journal of Antimicrobial Agents
September 12, 2019
Cited by 55


Related Papers